WPD Pharmaceuticals Inc WPDPF

Prepayment of $705,000

[etcetera]

WPD Pharmaceuticals Receives Second Prepayment of $705,000 from Total $7.4 Million Grant for Development of WPD101

VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) --

WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or
“WPD”) a clinical-stage pharmaceutical company, is pleased to announce
that it has received a prepayment of approximately C$705,000 (2,000,000
PLN) and approval for reimbursement of approximately C$175,000
(500,000 PLN) from the Polish National Center for Research and Development (“NCRD”) granted by the European Union, under the Smart Growth Operational Program 2014-2020, for the further development of WPD101, the Company’s drug candidate targeting glioblastoma (“GBM”) which includes Phase I clinical studies.

more at :

https://www.globenewswire.com/news-release/2020/09/16/2094419/0/en/WPD-Pharmaceuticals-Receives-Second-Prepayment-of-705-000-from-Total-7-4-Million-Grant-for-Development-of-WPD101.html